Avid Bioservices Inc (CDMO)

[entdoc]

mojo, what do you do in your spare time? great stuff. thank you. FDA has signaled it wants "wow" data points, efficacy even a blind, greedy politician or financier can see without graphs-- nothing subtle requiring mathmatical analyses. Another anticancer fromulary Medicare entry is huge dollars, and to date monoclonal antibody performance in the arena of solid-cancer killers remains mostly underwhelming. It IS coming though, and PPHM is moving up on the leaders in that field. At this point Peregrine, PPHM, AND MABs remain equally obscure to the public and investor eye. The goal is control.(!) Not cure. Cancer similar to diabetes. I am comfortable that PPHM is definitely a leader in that arena.